Evidence map›Paper›PMID 32542027›Full record

ArticlePloS one2020

Semantic text mining in early drug discovery for type 2 diabetes.

Lena K Hansson, Rasmus Borup Hansen, Sune Pletscher-Frankild, Rudolfs Berzins, Daniel Hvidberg Hansen, Dennis Madsen, Sten B Christensen, Malene Revsbech Christiansen, Ulrika Boulund, Xenia Asbæk Wolf and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Lena K HanssonNovo Nordisk Research Centre Oxford, Novo Nordisk Ltd., Oxford, United Kingdom.
Rasmus Borup HansenIntomics A/S, Kgs. Lyngby, Denmark.ORCID 0000-0002-5899-0356
Sune Pletscher-FrankildIntomics A/S, Kgs. Lyngby, Denmark.
Rudolfs BerzinsIntomics A/S, Kgs. Lyngby, Denmark.
Daniel Hvidberg HansenIntomics A/S, Kgs. Lyngby, Denmark.
Dennis MadsenNovo Nordisk A/S, Bagsværd, Denmark.ORCID 0000-0003-2099-6880
Sten B ChristensenNovo Nordisk A/S, Bagsværd, Denmark.
Malene Revsbech ChristiansenIntomics A/S, Kgs. Lyngby, Denmark.
Ulrika BoulundIntomics A/S, Kgs. Lyngby, Denmark.
Xenia Asbæk WolfIntomics A/S, Kgs. Lyngby, Denmark.
Sonny Kim KjærulffIntomics A/S, Kgs. Lyngby, Denmark.
Martijn van de BuntNovo Nordisk A/S, Bagsværd, Denmark.
Søren TulinNovo Nordisk A/S, Bagsværd, Denmark.
Thomas Skøt JensenIntomics A/S, Kgs. Lyngby, Denmark.
Rasmus WernerssonIntomics A/S, Kgs. Lyngby, Denmark.ORCID 0000-0003-4417-9842
Jan Nygaard JensenNovo Nordisk Research Centre Oxford, Novo Nordisk Ltd., Oxford, United Kingdom.
Clinical Microbiomics (Denmark) · DKNovo Nordisk (Denmark) · DKNovo Nordisk (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurveying the scientific literature is an important part of early drug discovery; and with the ever-increasing amount of biomedical publications it is imperative to focus on the most interesting articles. Here we present a project that highlights new understanding (e.g. recently discovered modes of action) and identifies potential drug targets, via a novel, data-driven text mining approach to score type 2 diabetes (T2D) relevance. We focused on monitoring trends and jumps in T2D relevance to help us be timely informed of important breakthroughs.

methodsWe extracted over 7 million n-grams from PubMed abstracts and then clustered around 240,000 linked to T2D into almost 50,000 T2D relevant 'semantic concepts'. To score papers, we weighted the concepts based on co-mentioning with core T2D proteins. A protein's T2D relevance was determined by combining the scores of the papers mentioning it in the five preceding years. Each week all proteins were ranked according to their T2D relevance. Furthermore, the historical distribution of changes in rank from one week to the next was used to calculate the significance of a change in rank by T2D relevance for each protein.

resultsWe show that T2D relevant papers, even those not mentioning T2D explicitly, were prioritised by relevant semantic concepts. Well known T2D proteins were therefore enriched among the top scoring proteins. Our 'high jumpers' identified important past developments in the apprehension of how certain key proteins relate to T2D, indicating that our method will make us aware of future breakthroughs. In summary, this project facilitated keeping up with current T2D research by repeatedly providing short lists of potential novel targets into our early drug discovery pipeline.

Indexed as

AlgorithmsData MiningDiabetes Mellitus, Type 2Drug DiscoveryHumansProteinsSemanticsProteins

Identifiers

PMID32542027
PMCPMC7295186
OpenAlexW3035483169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.